Evotec

Evotec provides drug development and manufacturing services across all stages.

Evotec is leading the way in drug discovery services to discover the next generation of drugs higher efficacy and probability of success.

The page describes flexible access to CRO/CDMO services across the drug discovery and development continuum.

Evotec therapeutic areas expertise and approach centers around actively exploring diverse therapeutic areas to drive innovation and create novel treatment options.

The page offers a fact sheet comparing the ICH M12 guideline with 2020 FDA guidance.

The page offers a fact sheet comparing the ICH M12 guideline with the 2018 Japanese PMDA guideline on drug interaction.

The page discusses the 2024 ICH M12 guideline and how Cyprotex supports DDI studies.

The page compares ICH M12 and PMDA guidelines and describes how Cyprotex supports DDI studies.

Evotec SE announced the results of its Annual General Meeting.

The page introduces people who power Evotec.

The company integrates science, AI, and advanced technologies for drug discovery and development.

The page describes scientific collaborations and partnerships to advance drug discovery and development for medicines.

The page covers Evotec’s ethics and compliance policies, which are available for download in four languages.

The page lists locations across North America, Europe, and the UK.

Evotec is a global biotechnology company that works with partners on drug discovery and development.

Evotec says it is committed to protecting the data and information of people and organizations it interacts with, including website visitors and marketing email recipients.